Redmile Group, LLC

13F Holdings History for ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Symbol: ADCT on NYSE
Investment type: Equity / Common Shares, par value CHF 0.08 per share
Latest Disclosed Ownership: 15.7M shares
Security Ownership: 14%

Shares, Excluding Options vs Price

Value, Excluding Options

Redmile Group, LLC ownership in ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)

2025-08-14 - Redmile Group, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.7M shares of ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT). This represents 14% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Redmile Group, LLC	14%		$49M	15.7M			$3.13	13G/A	6/30/2025	14 Aug 2025 16:15:34

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	4.47%		$42M	15.7M			$2.68	Q2 2025
3/31/2025	2.09%		$22.1M	15.7M			$1.41	Q1 2025
12/31/2024	2.17%	0%	$31.2M	15.7M	-2,486	-0.02%	$1.99	Q4 2024
9/30/2024	2.91%	+0.07%	$49.4M	15.7M	+400,000	+2.62%	$3.15	Q3 2024
6/30/2024	2.92%		$48.3M	15.3M			$3.16	Q2 2024
3/31/2024	2.52%	-0.01%	$68.6M	15.3M	-59,100	-0.39%	$4.49	Q1 2024
12/31/2023	0.91%	+0.09%	$25.4M	15.3M	+1,150,272	+8.11%	$1.66	Q4 2023
9/30/2023	0.61%	+0.01%	$12.7M	14.2M	+128,110	+0.91%	$0.90	Q3 2023
6/30/2023	1.16%	+0.04%	$30.2M	14M	+484,686	+3.57%	$2.15	Q2 2023
3/31/2023	1.15%	+0.51%	$26.5M	13.6M	+5,974,400	+78.7%	$1.95	Q1 2023
12/31/2022	1.19%	+0.01%	$29.1M	7.59M	+78,820	+1.05%	$3.84	Q4 2022
9/30/2022	1.4%		$36.2M	7.51M			$4.82	Q3 2022
6/30/2022	2.28%	+0.02%	$59.7M	7.51M	+79,600	+1.07%	$7.95	Q2 2022
3/31/2022	3.41%	-0.01%	$109M	7.43M	-18,600	-0.25%	$14.69	Q1 2022
12/31/2021	3.42%	-0.04%	$151M	7.45M	-78,300	-1.04%	$20.20	Q4 2021
9/30/2021	3.57%	+0%	$204M	7.53M	+7,300	+0.1%	$27.16	Q3 2021
6/30/2021	2.71%	+0.07%	$183M	7.52M	+213,611	+2.92%	$24.35	Q2 2021
3/31/2021	2.51%	+0.16%	$178M	7.31M	+549,624	+8.13%	$24.41	Q1 2021
12/31/2020	2.62%	+0.16%	$216M	6.76M	+405,700	+6.39%	$32.01	Q4 2020
9/30/2020	3.85%	+0.5%	$210M	6.35M	+827,224	+15%	$32.99	Q3 2020
6/30/2020	4.78%	+4.78%	$259M	5.53M	+5,525,870	NEW	$46.81	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.